John Overdeck’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

John Overdeck’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-113,911	Closed	-$45.3K	–	3479
2023 Q3	$45.3K	Buy	113,911 +10,124	+10%	+$4.99K	﹤0.01%	2828
2023 Q2	$71.6K	Buy	+103,787	New	+$669K	﹤0.01%	2789
2021 Q1	–	Sell	-19,695	Closed	-$131K	–	4419
2020 Q4	$131K	Sell	19,695 -9,023	-31%	-$73.9K	﹤0.01%	3180
2020 Q3	$292K	Buy	+28,718	New	+$338K	﹤0.01%	2599

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

John Overdeck's BLPH Position: Q4 2023 in Review

John Overdeck sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 113,911 shares — an estimated $45.3K sold.

John Overdeck first reported a position in BLPH in Q3 2020 and held it in 4 quarters. The position peaked at $292K in Q3 2020. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

John Overdeck reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
John Overdeck sold 113,911 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $45.3K.
John Overdeck first reported a position in Bellerophon Therapeutics, Inc. in Q3 2020 and held it in 4 quarters.
John Overdeck's Bellerophon Therapeutics, Inc. position peaked at $292K in Q3 2020.
2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.